Story thread · 2 reports / 1 sources
Marcus outlines 2026 capex of $40M-$45M to $45M-$50M as group pace runs 3% ahead for 2026
seekingalpha.com · 11d
First report: Agios outlines $45M-$50M 2026 PK deficiency revenue as November 1 sickle cell PDUFA approaches — seekingalpha.com, 12d
The conversation · 0
Sign in to join the conversation.
No comments yet — start the thread.